NIH R01 · 2025
PROJECT SUMMARY / ABSTRACT Staphylococcus aureus associated pneumonia accounts for an estimated 50,000 staphylococcal infections annually in the United States. S. aureus is one of the leading etiologic agents of ventilator-associated pneumonia in the intensive care environment. S. aureus pneumonia has a high rate of mortality due to the prevalence of antibiotic resistance and lack of an effective vaccine. Although S. aureus colonization (30% of humans) is strongly associated with higher risks for clinical infections, most colonized individuals will not experience S. aureus infections, suggesting that S. aureus maintains a dedicated balance with the host. Our knowledge gaps between S. aureus…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.